199 related articles for article (PubMed ID: 21963461)
1. Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.
Opstad TB; Pettersen AA; Weiss TW; Akra S; Øvstebø R; Arnesen H; Seljeflot I
Clin Chim Acta; 2012 Jan; 413(1-2):113-20. PubMed ID: 21963461
[TBL] [Abstract][Full Text] [Related]
2. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
Brunner S; Kim JO; Methe H
Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.
Blankenberg S; Rupprecht HJ; Poirier O; Bickel C; Smieja M; Hafner G; Meyer J; Cambien F; Tiret L;
Circulation; 2003 Apr; 107(12):1579-85. PubMed ID: 12668489
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease.
Jguirim-Souissi I; Jelassi A; Slimani A; Addad F; Hassine M; Hamda KB; Najah M; Maatouk F; Rouis M; Slimane MN
Coron Artery Dis; 2011; 22(6):388-93. PubMed ID: 21606841
[TBL] [Abstract][Full Text] [Related]
6. Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals.
Yasmin ; McEniery CM; O'Shaughnessy KM; Harnett P; Arshad A; Wallace S; Maki-Petaja K; McDonnell B; Ashby MJ; Brown J; Cockcroft JR; Wilkinson IB
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1799-805. PubMed ID: 16709939
[TBL] [Abstract][Full Text] [Related]
7. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of circulating matrix metalloproteinase-9 are associated with a dysregulated cortisol rhythm--A case-control study of coronary artery disease.
Szymanowski A; Nijm J; Kristenson M; Jonasson L
Psychoneuroendocrinology; 2011 Jan; 36(1):139-43. PubMed ID: 20674181
[TBL] [Abstract][Full Text] [Related]
9. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
Drzewoski J; Sliwińska A; Przybyłowska K; Sliwiński T; Kasznicki J; Zurawska-Klis M; Kosmalski M; Majsterek I
Kardiol Pol; 2008 Oct; 66(10):1042-8; discussion 1049. PubMed ID: 19006025
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
Hlatky MA; Ashley E; Quertermous T; Boothroyd DB; Ridker P; Southwick A; Myers RM; Iribarren C; Fortmann SP; Go AS;
Am Heart J; 2007 Dec; 154(6):1043-51. PubMed ID: 18035073
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus.
Wang Y; Su Y; Xu Y; Pan SH; Liu GD
Biochem Biophys Res Commun; 2010 Jan; 391(1):113-7. PubMed ID: 19909726
[TBL] [Abstract][Full Text] [Related]
13. A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction.
Koh YS; Chang K; Kim PJ; Seung KB; Baek SH; Shin WS; Lim SH; Kim JH; Choi KB
Int J Cardiol; 2008 Jul; 127(3):430-2. PubMed ID: 17698228
[TBL] [Abstract][Full Text] [Related]
14. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
[TBL] [Abstract][Full Text] [Related]
15. A functional matrix metalloproteinase (MMP)-9 polymorphism modifies plasma MMP-9 levels in subjects environmentally exposed to mercury.
Jacob-Ferreira AL; Passos CJ; Gerlach RF; Barbosa F; Tanus-Santos JE
Sci Total Environ; 2010 Sep; 408(19):4085-92. PubMed ID: 20554312
[TBL] [Abstract][Full Text] [Related]
16. Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels.
Marson BP; Lacchini R; Belo V; Mattos SG; da Costa BP; Poli-de-Figueiredo CE; Tanus-Santos JE
Clin Chim Acta; 2012 Dec; 414():46-51. PubMed ID: 23010359
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
[TBL] [Abstract][Full Text] [Related]
18. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
Ozkök E; Aydin M; Babalik E; Ozbek Z; Ince N; Kara I
Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194
[TBL] [Abstract][Full Text] [Related]
19. Role of proinflammatory alleles in longevity and atherosclerosis: results of studies performed on -1562C/T MMP-9 in centenarians and myocardial infarction patients from Sicily.
Nuzzo D; Vasto S; Balistreri CR; Di-Carlo D; Listì F; Caimi G; Caruso M; Hoffmann E; Incalcaterra E; Lio D; Caruso C; Candore G
Ann N Y Acad Sci; 2006 Nov; 1089():496-501. PubMed ID: 17261792
[TBL] [Abstract][Full Text] [Related]
20. Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease.
Jguirim-Souissi I; Jelassi A; Addad F; Hassine M; Najah M; Ben Hamda K; Maatouk F; Ben Farhat M; Bouslema A; Rouis M; Slimane MN
Am J Cardiol; 2007 Jul; 100(1):23-7. PubMed ID: 17599435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
